Serum FABP4, AFP, and MCP-1 Levels in Gastric Adenocarcinoma Patients
Gastric adenocarcinoma accounts for approximately 95% of gastric malignancies, predominantly occurring in individuals over 50 years of age. It exhibits low sensitivity to chemotherapy and radiotherapy, resulting in high incidence and mortality rates, with overall poor prognosis [1]. The disease typically presents no symptoms in its early stages; as it progresses, patients may experience gastric … Read more